Novo Holdings A/S 13D/13G Filings for Mirum Pharmaceuticals, Inc. (MIRM)

Novo Holdings A/S 13D and 13G filings for Mirum Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-08-18
1:30 pm
Sale		 2022-08-12 13D Mirum Pharmaceuticals, Inc.
MIRM		 Novo Holdings A/S 1,760,000
4.800%		 -129,127decrease
(-6.84%)		 Filing
2022-08-02
3:31 pm
Sale		 2022-08-01 13D Mirum Pharmaceuticals, Inc.
MIRM		 Novo Holdings A/S 1,889,127
5.900%		 -310,873decrease
(-14.13%)		 Filing
2022-04-08
2:49 pm
Sale		 2022-03-31 13D Mirum Pharmaceuticals, Inc.
MIRM		 Novo Holdings A/S 2,200,000
6.900%		 -245,147decrease
(-10.03%)		 Filing
2021-08-24
4:32 pm
Unchanged		 2021-08-19 13D Mirum Pharmaceuticals, Inc.
MIRM		 Novo Holdings A/S 2,445,147
8.000%		 0
(Unchanged)		 Filing
2020-12-18
4:31 pm
Unchanged		 2020-12-15 13D Mirum Pharmaceuticals, Inc.
MIRM		 Novo Holdings A/S 2,445,147
8.400%		 0
(Unchanged)		 Filing